American Biotech Innovator Named Caribbean Science and Technology Laureate

Dr. Niven R. Narain recognized for pioneering patient biology drug discovery platform powered by AI

Published on Feb. 10, 2026

American biotech innovator Dr. Niven R. Narain has been named the joint Science and Technology Laureate for 2026 by the Anthony N. Sabga Awards Caribbean Excellence program. Dr. Narain, based in Boston, created the world's first fully integrated patient biology drug discovery platform powered by artificial intelligence, resulting in over 650 patents, 100 scientific publications, and 70 global partnerships.

Why it matters

The prestigious Sabga Laureate award, often called the 'Caribbean's Nobel Prize,' recognizes Dr. Narain's remarkable ability to connect global research efforts and foster studies that aim to bring precision medicine to Caribbean communities. His groundbreaking work has revealed insights into more aggressive cancers affecting Caribbean populations and launched tech-driven projects to better understand and manage diseases like type 2 diabetes.

The details

Dr. Narain's platform has resulted in more than 650 patents worldwide, over 100 impactful scientific publications, and more than 70 global partnerships with top medical schools, hospitals, governments, and pharmaceutical companies. Several medicines developed with his platform are now in advanced clinical trials and are undergoing review by the US Food and Drug Administration for treating conditions ranging from aggressive cancers to rare skin disorders, sarcopenia, and childhood mitochondrial issues.

  • The Anthony N. Sabga Awards Caribbean Excellence Laureates for 2026 were announced on February 2, 2026.

The players

Dr. Niven R. Narain

An American biotech innovator and co-founder and president of a Boston-based biotech firm, Dr. Narain is passionate about the technological intersection of systems medicine and AI.

Maria Superville Neielson

The awards program director for the Anthony N. Sabga Awards Caribbean Excellence.

Michelle Carchedi

The president of Alternatives, Inc., a nonprofit dedicated to promoting patient-centered, direct-payment healthcare models.

Anthony N. Sabga

The founder of the awards program that bears his name, celebrating Caribbean nationals who demonstrate exceptional excellence.

Alternatives, Inc.

A 501(c)(3) nonprofit dedicated to promoting patient-centered, direct-payment healthcare models.

Got photos? Submit your photos here. ›

What they’re saying

“It is a great honor to be named as 2026 Sabga Laureate, we are now comfortably in the century of biology, and the understanding of patient populations will change the face of how we understand, treat, and manage disease. I am humbled and thankful to be able to advance leading-edge American innovation throughout the world while bringing the voice of Caribbean biology into the global ecosystem of innovation.”

— Dr. Niven R. Narain

“This prestigious recognition, often dubbed the Caribbean's 'Nobel Prize,' places Dr. Niven R. Narain among an elite group of trailblazers actively shaping the region's future.”

— Michelle Carchedi, President of Alternatives, Inc.

The takeaway

Dr. Narain's pioneering work in patient biology and AI-powered drug discovery is not only advancing global medical innovation, but also bringing cutting-edge precision medicine to underserved Caribbean communities, demonstrating the power of cross-border collaboration to drive meaningful progress in healthcare.